vs

Side-by-side financial comparison of Hudson Pacific Properties, Inc. (HPP) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

Hudson Pacific Properties, Inc. is the larger business by last-quarter revenue ($256.0M vs $151.7M, roughly 1.7× Tarsus Pharmaceuticals, Inc.). Tarsus Pharmaceuticals, Inc. runs the higher net margin — -5.5% vs -109.4%, a 103.9% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 22.1%). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs 13.0%).

Hudson Pacific Properties is a real estate investment trust with 15.8 million square feet of office buildings, 1.5 million square feet of sound stages, and undeveloped rights for 3 million square feet of additional commercial property. Its properties are on the West Coast of the United States and Vancouver. It is organized in Maryland and headquartered in Los Angeles. It is the largest independent operator of sound stages in Los Angeles.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

HPP vs TARS — Head-to-Head

Bigger by revenue
HPP
HPP
1.7× larger
HPP
$256.0M
$151.7M
TARS
Growing faster (revenue YoY)
TARS
TARS
+106.3% gap
TARS
128.4%
22.1%
HPP
Higher net margin
TARS
TARS
103.9% more per $
TARS
-5.5%
-109.4%
HPP
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
13.0%
HPP

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HPP
HPP
TARS
TARS
Revenue
$256.0M
$151.7M
Net Profit
$-280.2M
$-8.4M
Gross Margin
Operating Margin
18.6%
-5.3%
Net Margin
-109.4%
-5.5%
Revenue YoY
22.1%
128.4%
Net Profit YoY
-61.5%
63.8%
EPS (diluted)
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HPP
HPP
TARS
TARS
Q3 26
$256.0M
Q1 26
$181.9M
Q4 25
$256.0M
$151.7M
Q3 25
$186.6M
$118.7M
Q2 25
$190.0M
$102.7M
Q1 25
$198.5M
$78.3M
Q4 24
$209.7M
$66.4M
Q3 24
$200.4M
$48.1M
Net Profit
HPP
HPP
TARS
TARS
Q3 26
$-280.2M
Q1 26
$-50.9M
Q4 25
$-280.2M
$-8.4M
Q3 25
$-144.1M
$-12.6M
Q2 25
$-87.8M
$-20.3M
Q1 25
$-80.3M
$-25.1M
Q4 24
$-173.5M
$-23.1M
Q3 24
$-107.0M
$-23.4M
Gross Margin
HPP
HPP
TARS
TARS
Q3 26
Q1 26
Q4 25
60.0%
Q3 25
44.3%
Q2 25
43.1%
Q1 25
42.9%
Q4 24
44.7%
Q3 24
42.7%
Operating Margin
HPP
HPP
TARS
TARS
Q3 26
18.6%
Q1 26
-7.1%
Q4 25
-109.8%
-5.3%
Q3 25
-77.2%
-12.2%
Q2 25
-46.0%
-21.6%
Q1 25
-40.4%
-33.5%
Q4 24
-83.2%
-36.8%
Q3 24
-52.3%
-52.3%
Net Margin
HPP
HPP
TARS
TARS
Q3 26
-109.4%
Q1 26
-28.0%
Q4 25
-109.4%
-5.5%
Q3 25
-77.2%
-10.6%
Q2 25
-46.2%
-19.8%
Q1 25
-40.5%
-32.1%
Q4 24
-82.7%
-34.8%
Q3 24
-53.4%
-48.7%
EPS (diluted)
HPP
HPP
TARS
TARS
Q3 26
Q1 26
Q4 25
$-11.57
$-0.17
Q3 25
$-0.30
$-0.30
Q2 25
$-0.41
$-0.48
Q1 25
$-0.53
$-0.64
Q4 24
$-1.19
$-0.57
Q3 24
$-0.69
$-0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HPP
HPP
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$138.4M
$417.3M
Total DebtLower is stronger
$72.4M
Stockholders' EquityBook value
$3.2B
$343.4M
Total Assets
$7.3B
$562.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HPP
HPP
TARS
TARS
Q3 26
$138.4M
Q1 26
$138.0M
Q4 25
$138.4M
$417.3M
Q3 25
$190.4M
$401.8M
Q2 25
$236.0M
$381.1M
Q1 25
$86.5M
$407.9M
Q4 24
$63.3M
$291.4M
Q3 24
$90.7M
$317.0M
Total Debt
HPP
HPP
TARS
TARS
Q3 26
Q1 26
Q4 25
$72.4M
Q3 25
$72.3M
Q2 25
$72.1M
Q1 25
$72.0M
Q4 24
$71.8M
Q3 24
$71.7M
Stockholders' Equity
HPP
HPP
TARS
TARS
Q3 26
$3.2B
Q1 26
$3.1B
Q4 25
$3.0B
$343.4M
Q3 25
$3.2B
$335.1M
Q2 25
$3.4B
$332.6M
Q1 25
$2.8B
$342.5M
Q4 24
$2.9B
$224.5M
Q3 24
$3.0B
$237.5M
Total Assets
HPP
HPP
TARS
TARS
Q3 26
$7.3B
Q1 26
$7.2B
Q4 25
$7.3B
$562.2M
Q3 25
$7.8B
$534.6M
Q2 25
$8.1B
$495.0M
Q1 25
$8.0B
$500.8M
Q4 24
$8.1B
$377.0M
Q3 24
$8.3B
$376.3M
Debt / Equity
HPP
HPP
TARS
TARS
Q3 26
Q1 26
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HPP
HPP
TARS
TARS
Operating Cash FlowLast quarter
$19.3M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
8.6%
Capex IntensityCapex / Revenue
14.0%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HPP
HPP
TARS
TARS
Q3 26
Q1 26
Q4 25
$121.0M
$19.3M
Q3 25
$33.2M
$18.3M
Q2 25
$-2.0M
$-29.4M
Q1 25
$30.5M
$-20.7M
Q4 24
$164.7M
$-22.2M
Q3 24
$63.7M
$-8.7M
Free Cash Flow
HPP
HPP
TARS
TARS
Q3 26
Q1 26
Q4 25
$13.0M
Q3 25
$16.3M
Q2 25
$-30.4M
Q1 25
$-21.2M
Q4 24
$-22.3M
Q3 24
$-8.9M
FCF Margin
HPP
HPP
TARS
TARS
Q3 26
Q1 26
Q4 25
8.6%
Q3 25
13.8%
Q2 25
-29.6%
Q1 25
-27.1%
Q4 24
-33.5%
Q3 24
-18.6%
Capex Intensity
HPP
HPP
TARS
TARS
Q3 26
14.0%
Q1 26
18.5%
Q4 25
4.2%
Q3 25
1.6%
Q2 25
1.0%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HPP
HPP

Rental revenues$216.8M85%
Other$35.6M14%
Service and other revenues$3.7M1%

TARS
TARS

Segment breakdown not available.

Related Comparisons